Order Center
Product Name or No.
Keyword (Full Text)
MISSION shRNA-RNAi
MISSION siRNA
Molecular Formula
CAS No.
MDL No.
MSDS (Prod. No. Only)
Supplier X Reference
SubStructure
YFG Search
Product Catalog
→
Cancer Research
→
Antitumor Agents
→ Therapy Adjuncts
Print Preview
Therapy Adjuncts
Scroll Up
Scroll Down
Reset Table
Image
Description
Biochem/physiol Actions
CAS Number
Product #
(−)-Scopolamine hydrobromide trihydrate ≥98% (TLC), powder
Competitive nonselective muscarinic acetylcholine antagonist. Scopolamine-induced amnesia in laboratory animals is a commonly-used model of memory deficit.
114-49-8
S1875
4-Amino-1,8-naphthalimide
Sensitizes cells to radiation-induced cell damage and enhances the cytotoxicity of 1-methyl-3-nitro-1-nitrosoguanidine.
1742-95-6
A0966
Amifostine ≥97% (TLC), powder
Radioprotective agent. Selectively protects normal tissues from the damaging effects of anti-neoplastic radiation therapy. Selectivity is due to preferential uptake by normal tissues and subsequent metabolic activation to 2-(3-aminopropyl)aminoethanethiol.
20537-88-6
A5922
Brefeldin A from
Penicillium brefeldianum
, ≥99% (HPLC and TLC)
Brefeldin A (BFA) is a fungal metabolite which disrupts the structure and function of the Golgi apparatus. BFA is an activator of the sphingomyelin cycle. Brefeldin A-mediated apoptosis has been observed in human tumor cells.
20350-15-6
B7651
Cimetidine
H
2
histamine receptor antagonist; I
1
imidazoline receptor agonist; anti-ulcer agent. Blocks cancer metastasis by inhibiting the expression of E-selectin on the surface of endothelial cells, thus blocking tumor cell adhesion.
51481-61-9
C4522
Lectin from
Viscum album
(European mistletoe) lyophilized powder
VAA is not blood group specific, but has an affinity for terminal β-
D
-galactosyl residues.
1
VAA inhibits protein synthesis similarly to Ricin (RCA
60
) and inhibits allergen induced histamine release
in vitro
from human leukocytes.
2
L2662
Leuprolide acetate salt ≥98% (HPLC)
Luteinizing hormone releasing hormone (LH-RH) agonist.
74381-53-6
L0399
Luteinizing hormone releasing hormone human acetate salt ≥98% (HPLC), powder
Hypothalamic peptide that stimulates release of gonadotrophins from anterior pituitary, thus regulating reproductive functions.
71447-49-9
L7134
Papaverine hydrochloride powder
Smooth muscle relaxant and cerebral vasodilator; phosphodiesterase inhibitor.
61-25-6
P3510
Phosphomycin disodium salt
Antibiotic that concentrates in kidney and bladder; reduces nephrotoxicity and ototoxicity of platinum-containing anti-tumor agents. Fosfomycin inhibits UDP-GlcNAc enolpyruvyl tranferase (MurA), an enzyme involved in bacterial cell wall biosynthesis.
26016-99-9
P5396
Pifithrin-α ≥95% (HPLC), powder
Pifithrin-α is a reversible inhibitor of p53-mediated apoptosis and p53-dependent gene transcription such as cyclin G, p21/waf1, and mdm2 expression. Pifithrin-α enhances cell survival after genotoxic stress such as UV irradiation and treatment with cytotoxic compounds including doxorubicin, etopoxide, paclitaxel, and cytosine-β-D-arabinofuranoside. Pifithrin-α protects mice from lethal whole body γ-irradiation without an increase in cancer incidence. The protective effect is not seen in p53-null mice or cells expressing a dominant negative mutant of the p53 gene. Protection is conferred by the transient expression of p53 in p53-deficient cell lines.
63208-82-2
P4359
Thapsigargin ≥90% (HPLC), liquid or film
Potent, cell-permeable, IP
3
-independent intracellular calcium releaser. Blocks the transient increase in intracellular Ca
2+
induced by angiostatin and endostatin. Induces apoptosis by disrupting intracellular free Ca
2+
levels; incorporated into chemotherapeutic prodrug formulations.
67526-95-8
T9033
[
D
-Lys
6
]-
LH-RH ≥95% (HPLC), powder
LH-RH agonist. It has been conjugated to cytotoxic compounds such as methotrexate (MTX), doxorubicin (DOX), and glutaryl-2-(hydroxymethyl)anthraquinone (G-HMAQ), and together with other conjugated LH-RH analogs comprise a class of targeted chemotherapeutic agents for cancers expressing receptors for LH-RH.
52671-12-2
L5022
[
D
-Trp
6
]-
LH-RH ≥97% (HPLC), powder
Potent LH-RH agonist with enhanced biological activity due to its slower rate of degradation. Like [
D
-Lys
6
]-LH-RH, the
D
-Trp
6
analog has been shown to be effective against cancers expressing the LH-RH receptor. However, unlike the
D
-Lys
6
analog, it is generally used in the unconjugated form.
57773-63-4
L9761
Site Use Terms
|
Terms and Conditions of Sale
|
Privacy
|
Copyrights © 2008 Sigma-Aldrich Co. All Rights Reserved. Reproduction of any materials from the site is strictly forbidden without permission. Sigma-Aldrich brand products are sold exclusively through Sigma-Aldrich, Inc.